EUZ — Eckert & Ziegler SE Share News
0.000.00%
Last trade - 00:00- €770.94m
- €703.00m
- €311.96m
Brief: Eckert & Ziegler Says Capital Increase Entered In Commercial Register
Factbox: Cyber threats disrupt global firms in US, UK and EU
Factbox: Cyber threats disrupt global firms in US, UK and Europe
Brief: Eckert & Ziegler Q1 Sales EUR 68.2 Million
Brief: Eckert & Ziegler Q1 Revenue At EUR 68.2 Mln
Brief: Eckert & Ziegler and Pentixapharm Sign Manufacturing Agreement Limited To Clinical Development Phase
Brief: Eckert & Ziegler Proposes Dividend Of €0.50 For FY 2024
Brief: Eckert & Ziegler FY EPS EUR 1.6
Brief: Eckert & Ziegler To Supply Actinium Pharmaceuticals With AC-225 For Comprehensive Development Activities
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities
Brief: Eckert & Ziegler And Atomvie Global Radiopharma Announce Global Supply Agreement
Brief: Eckert & Ziegler Enters Partnership With Bicycle Therapeutics
Brief: Eckert & Ziegler Ensures Business Continuity After Cyber-Attack
Brief: Eckert & Ziegler Says Suffered Cyber Attack On Parts Of Its IT Systems
Brief: Eckert & Ziegler It Incident Affects Communication Channels
Brief: Eckert & Ziegler FY Net Income EUR 33 Million
Brief: Eckert & Ziegler Signs Licence Agreement For Actinium-225 With Chinese Joint Venture
Brief: Eckert & Ziegler And Glytherix Extend Collaboration With Actinium-225 Supply Agreement
Brief: Eqs-News Eckert & Ziegler Submits Galliapharm® For Approval By Japan’S Health Authority Mhlw